ROLFE LINDSEY (See Remarks) sold 3.9% of their position (4.33K shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $6.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/3/2022ACC: 0000899243-22-027577
Officer· See Remarks
Since Sep 2018
-4.33K
Net shares
Net seller
$6.3K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
8.37K acquired · 12.70K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
3.6%
8/1/2022
103.02K→106.77K
Common Stock
Direct
Shares
+4.63K
Price / share
—
Trade value
—
% of position
4.4%
8/1/2022
104.83K→109.45K
Common Stock
Direct
Shares
−1.94K
Price / share
$1.46
Trade value
$2.83K
% of position
1.8%
8/2/2022
106.77K→104.83K
Common Stock
Direct
Shares
−2.39K
Price / share
$1.46
Trade value
$3.49K
% of position
2.2%
8/2/2022
109.45K→107.06K
Total
Net shares
+4.04K
Net value
-$6.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2022 | M · Option Exercise | +3.75K | — | — | 3.6% | 103.02K | 106.77K |
| Common Stock Direct | 8/1/2022 | M · Option Exercise | +4.63K | — | — | 4.4% | 104.83K | 109.45K |
| Common Stock Direct | 8/2/2022 | S · Sale | −1.94K | $1.46 | $2.83K | 1.8% | 106.77K | 104.83K |
| Common Stock Direct | 8/2/2022 | S · Sale | −2.39K | $1.46 | $3.49K | 2.2% | 109.45K | 107.06K |
| Total | +4.04K | -$6.33K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
7.50K
Exercisable
—
8/1/2022
Restricted Stock Units
Direct
Converts to
Common Stock
4.63K shares
Shares
−4.63K
Strike price
Held after
27.75K
Exercisable
—
8/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 8/1/2022 | M · Option Exercise | −3.75K | — | 7.50K | |
| Restricted Stock Units Direct | Common Stock4.63K shares | 8/1/2022 | M · Option Exercise | −4.63K | — | 27.75K |